DrWatson 26 RP AUS - Pharma meets cannabis

DrWatson 26 Rainbow Pavé AUS is a Sativa dominant hybrid cultivar from original Compound Genetics, developed under the direction of Chris Lynch and cultivated as part of the DrWatson line at Breathe Life Sciences in Australia. The cultivar is characterized by a balanced, compact flower structure with dense trichome coverage and stands for modern, sensory, clearly defined genetics in the premium segment. The terpene profile is predominantly
characterized by limonene, B-caryophyllene and myrcene and supports a
mood-enhancing and at the same time physically balancing effect. Aromatically, Rainbow Pavé is fruity and precisely differentiated, with sweet, slightly creamy base notes that are accompanied by clearly perceptible citrus freshness and fine earthy components. The profile is structured, reproducible and clean on the finish, which enables a consistent sensory evaluation in a medicinal context. The effect is described as clear-acting, mentally uplifting and physically relaxing. The effects and properties described are based on statements and reports from patients and user experience.